Antiviral Drug News and Research

RSS
Keck Medicine of USC participates in clinical trial to evaluate antiviral drug as possible COVID-19 treatment

Keck Medicine of USC participates in clinical trial to evaluate antiviral drug as possible COVID-19 treatment

Absolute Antibody and University of Zurich partner to offer novel SARS-CoV-2 sybodies

Absolute Antibody and University of Zurich partner to offer novel SARS-CoV-2 sybodies

Innovative clinical trial platform launched to accelerate testing of COVID-19 drugs

Innovative clinical trial platform launched to accelerate testing of COVID-19 drugs

Scientists identify compounds that block replication of COVID-19 virus

Scientists identify compounds that block replication of COVID-19 virus

New platform prioritizes synergistic drug combinations against SARS-CoV-2

New platform prioritizes synergistic drug combinations against SARS-CoV-2

CityU develops CRISPR-assisted method to identify RNA-binding proteins in living cells

CityU develops CRISPR-assisted method to identify RNA-binding proteins in living cells

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Pixatimod is active in lab studies against SARS-CoV-2

Pixatimod is active in lab studies against SARS-CoV-2

SARS-CoV-2 can replicate in human pediatric gastric organoids

SARS-CoV-2 can replicate in human pediatric gastric organoids

New assay rapidly tests SARS-CoV-2 neutralization and screens antivirals

New assay rapidly tests SARS-CoV-2 neutralization and screens antivirals

Statin therapy linked to lower death rate in hospitalized patients with COVID-19

Statin therapy linked to lower death rate in hospitalized patients with COVID-19

Scientists create 'all-atom' model of SARS-CoV-2 spike protein

Scientists create 'all-atom' model of SARS-CoV-2 spike protein

Favipiravir has weak effect on SARS-CoV-2 and Hydroxychloroquine none at all in hamster model

Favipiravir has weak effect on SARS-CoV-2 and Hydroxychloroquine none at all in hamster model

Researchers produce first fully-glycosylated full-length SARS-CoV-2 spike protein models

Researchers produce first fully-glycosylated full-length SARS-CoV-2 spike protein models

Experimental drug to prevent deadly blood coagulation in patients with COVID-19

Experimental drug to prevent deadly blood coagulation in patients with COVID-19

Inhibition of coronavirus spike protein binding to ACE2

Inhibition of coronavirus spike protein binding to ACE2

Convalescent plasma therapy improves outcomes in majority of COVID-19 patients

Convalescent plasma therapy improves outcomes in majority of COVID-19 patients

Study shows Sofosbuvir alleviates COVID-19-related neurological symptoms

Study shows Sofosbuvir alleviates COVID-19-related neurological symptoms

Approach used against influenza epidemics could benefit COVID-19 drug development

Approach used against influenza epidemics could benefit COVID-19 drug development

SwRI receives $1.9 million to identify potential treatments for COVID-19

SwRI receives $1.9 million to identify potential treatments for COVID-19